Vaxcyte (NASDAQ:PCVX) Earns Buy Rating from Analysts at Mizuho
Mizuho initiated coverage on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a research report report published on Thursday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $69.00 target price on the stock. Several other research firms have also recently commented on PCVX. Cantor Fitzgerald reiterated an overweight rating and set a […]